SG11201401021TA - Pyrrolobenzodiazepines - Google Patents
PyrrolobenzodiazepinesInfo
- Publication number
- SG11201401021TA SG11201401021TA SG11201401021TA SG11201401021TA SG11201401021TA SG 11201401021T A SG11201401021T A SG 11201401021TA SG 11201401021T A SG11201401021T A SG 11201401021TA SG 11201401021T A SG11201401021T A SG 11201401021TA SG 11201401021T A SG11201401021T A SG 11201401021TA
- Authority
- SG
- Singapore
- Prior art keywords
- pyrrolobenzodiazepines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/65—Peptidic linkers, binders or spacers, e.g. peptidic enzyme-labile linkers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161547198P | 2011-10-14 | 2011-10-14 | |
| PCT/EP2012/070233 WO2013053873A1 (en) | 2011-10-14 | 2012-10-12 | Pyrrolobenzodiazepines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201401021TA true SG11201401021TA (en) | 2014-08-28 |
Family
ID=47019020
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201401021TA SG11201401021TA (en) | 2011-10-14 | 2012-10-12 | Pyrrolobenzodiazepines |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9399073B2 (en) |
| EP (1) | EP2751111B1 (en) |
| JP (1) | JP6170497B2 (en) |
| KR (1) | KR101891859B1 (en) |
| CN (1) | CN103998450B (en) |
| AU (1) | AU2012322934B2 (en) |
| BR (1) | BR112014008888A2 (en) |
| CA (1) | CA2850103C (en) |
| EA (1) | EA028457B1 (en) |
| MX (1) | MX341523B (en) |
| SG (1) | SG11201401021TA (en) |
| WO (1) | WO2013053873A1 (en) |
Families Citing this family (113)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| BR112012026410B8 (en) | 2010-04-15 | 2023-01-31 | Spirogen Dev Sarl | COMPOUND AND CONJUGATE OF PYROLOBENZODIAZEPINE AND USES THEREOF |
| JP5870400B2 (en) | 2010-04-15 | 2016-03-01 | シアトル ジェネティクス，インコーポレーテッド | Targeted pyrrolobenzodiazepine conjugates |
| KR101860174B1 (en) | 2011-09-20 | 2018-05-21 | 메디뮨 리미티드 | Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| EP2751110B1 (en) | 2011-10-14 | 2017-04-19 | MedImmune Limited | Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative and autoimmune diseases |
| WO2013053873A1 (en) | 2011-10-14 | 2013-04-18 | Spirogen Sàrl | Pyrrolobenzodiazepines |
| WO2013055993A1 (en) | 2011-10-14 | 2013-04-18 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| CN103987384A (en) | 2011-10-14 | 2014-08-13 | 西雅图基因公司 | Pyrrolobenzodiazepines and targeted conjugates |
| US9931414B2 (en) | 2012-10-12 | 2018-04-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| PL2906253T3 (en) | 2012-10-12 | 2019-02-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
| RS56520B1 (en) | 2012-10-12 | 2018-02-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| EP2906296B1 (en) | 2012-10-12 | 2018-03-21 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| LT2839860T (en) | 2012-10-12 | 2019-07-10 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| EP2906249B1 (en) | 2012-10-12 | 2018-06-27 | MedImmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| WO2014057114A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| CN110256469B (en) | 2012-10-12 | 2022-05-17 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines and conjugates thereof |
| CN110452242A (en) | 2012-12-21 | 2019-11-15 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines Zhuo and its conjugate |
| JP6527466B2 (en) | 2012-12-21 | 2019-06-05 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | Asymmetric pyrrolobenzodiazepine dimers for use in the treatment of proliferative and autoimmune diseases |
| KR102274714B1 (en) | 2013-03-13 | 2021-07-09 | 씨젠 인크. | Cyclodextrin and antibody-drug conjugate formulations |
| HUE042373T2 (en) | 2013-03-13 | 2019-06-28 | Seattle Genetics Inc | Activated carbon filtration for purification of benzodiazepine adcs |
| EA027910B1 (en) | 2013-03-13 | 2017-09-29 | Медимьюн Лимитед | Pyrrolobenzodiazepines and conjugates thereof |
| JP6340019B2 (en) | 2013-03-13 | 2018-06-06 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | Pyrrolobenzodiazepine and its conjugates |
| WO2014145090A1 (en) | 2013-03-15 | 2014-09-18 | Regeneron Pharmaceuticals, Inc. | Biologically active molecules, conjugates thereof, and therapeutic uses |
| CA2921412A1 (en) | 2013-08-26 | 2015-03-05 | Regeneron Pharmaceuticals, Inc. | Pharmaceutical compositions comprising macrolide diastereomers, methods of their synthesis and therapeutic uses |
| MX2016002547A (en) | 2013-08-28 | 2016-06-17 | Stemcentrx Inc | Site-specific antibody conjugation methods and compositions. |
| CA2922544A1 (en) * | 2013-08-28 | 2015-03-05 | Stemcentrx, Inc. | Engineered anti-dll3 conjugates and methods of use |
| MX2016002574A (en) | 2013-08-28 | 2016-06-14 | Stemcentrx Inc | Novel sez6 modulators and methods of use. |
| EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| US9956299B2 (en) | 2013-10-11 | 2018-05-01 | Medimmune Limited | Pyrrolobenzodiazepine—antibody conjugates |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| EP3054985B1 (en) | 2013-10-11 | 2018-12-26 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| CA2921707C (en) | 2013-10-15 | 2023-03-28 | Seattle Genetics, Inc. | Pegylated drug-linkers for improved ligand-drug conjugate pharmacokinetics |
| CN103641834B (en) * | 2013-12-12 | 2015-12-09 | 沈阳药科大学 | Pyrrolobenzodiazepines * compounds and its preparation method and application |
| EA033456B1 (en) * | 2013-12-16 | 2019-10-31 | Genentech Inc | Antibody-drug conjugates comprising peptidomimetic linkers |
| SG11201610465PA (en) | 2013-12-19 | 2017-01-27 | Seattle Genetics Inc | Methylene carbamate linkers for use with targeted-drug conjugates |
| PE20161209A1 (en) | 2014-02-21 | 2016-11-10 | Abbvie Stemcentrx Llc | CONJUGATES OF ANTI-DROSOPHILA SIMILAR ANTIBODIES TO DELTA 3 (ANTI-DLL3) AND DRUGS FOR USE IN THE TREATMENT OF MELANOMA |
| SG11201606979TA (en) | 2014-03-11 | 2016-09-29 | Regeneron Pharma | Anti-egfrviii antibodies and uses thereof |
| CN106687141A (en) | 2014-09-10 | 2017-05-17 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines and conjugates thereof |
| GB201416112D0 (en) | 2014-09-12 | 2014-10-29 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| MA40576B1 (en) | 2014-09-12 | 2020-11-30 | Genentech Inc | Anti-her2 antibodies and immunoconjugates |
| US10780096B2 (en) | 2014-11-25 | 2020-09-22 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-antibody conjugates |
| CA2973354A1 (en) | 2015-01-14 | 2016-07-21 | Bristol-Myers Squibb Company | Benzodiazepine dimers, conjugates thereof, and methods of making and using |
| PE20171185A1 (en) | 2015-01-14 | 2017-08-22 | Bristol Myers Squibb Co | BENZODIAZEPINE DIMERS UNITED WITH HETEROARYLENE BRIDGES, CONJUGATES OF THESE, AND THEIR METHODS OF PREPARATION AND USE |
| BR112017020149A8 (en) | 2015-03-27 | 2023-05-02 | Regeneron Pharma | MAITANSINOID DERIVATIVES, CONJUGATES THEREOF AND METHODS OF USE |
| GB201506402D0 (en) | 2015-04-15 | 2015-05-27 | Berkel Patricius H C Van And Howard Philip W | Site-specific antibody-drug conjugates |
| GB201506411D0 (en) | 2015-04-15 | 2015-05-27 | Bergenbio As | Humanized anti-axl antibodies |
| WO2016209951A1 (en) | 2015-06-23 | 2016-12-29 | Bristol-Myers Squibb Company | Macrocyclic benzodiazepine dimers, conjugates thereof, preparation and uses |
| IL296285A (en) | 2015-07-06 | 2022-11-01 | Regeneron Pharma | Multispecific antigen-binding molecules and uses thereof |
| MA43345A (en) | 2015-10-02 | 2018-08-08 | Hoffmann La Roche | PYRROLOBENZODIAZEPINE ANTIBODY-DRUG CONJUGATES AND METHODS OF USE |
| CA3006000A1 (en) | 2015-12-04 | 2017-06-08 | Seattle Genetics, Inc. | Conjugates of quaternized tubulysin compounds |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| EP3387017A1 (en) | 2015-12-11 | 2018-10-17 | Regeneron Pharmaceuticals, Inc. | Methods for reducing or preventing growth of tumors resistant to egfr and/or erbb3 blockade |
| MX2018008987A (en) | 2016-01-25 | 2018-11-19 | Regeneron Pharma | Maytansinoid derivatives, conjugates thereof, and methods of use. |
| GB201601431D0 (en) | 2016-01-26 | 2016-03-09 | Medimmune Ltd | Pyrrolobenzodiazepines |
| GB201602359D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| GB201602356D0 (en) | 2016-02-10 | 2016-03-23 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| CN109843919A (en) | 2016-03-25 | 2019-06-04 | 西雅图基因公司 | The method for being used to prepare the agent-linker and its intermediate of Pegylation |
| WO2017190079A1 (en) | 2016-04-28 | 2017-11-02 | Regeneron Pharmaceuticals, Inc. | Methods of making multispecific antigen-binding molecules |
| GB201607478D0 (en) | 2016-04-29 | 2016-06-15 | Medimmune Ltd | Pyrrolobenzodiazepine Conjugates |
| EP3458069B1 (en) | 2016-05-18 | 2023-07-05 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepines and conjugates thereof |
| WO2017223275A1 (en) | 2016-06-24 | 2017-12-28 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepines and conjugates thereof |
| EP3478324A1 (en) | 2016-07-01 | 2019-05-08 | GlaxoSmithKline Intellectual Property (No.2) Limited | Antibody-drug conjugates and therapeutic methods using the same |
| FI3515487T3 (en) | 2016-09-23 | 2023-08-15 | Regeneron Pharma | Bi specific anti-muc16-cd3 antibodies and anti-muc16 drug conjugates |
| CN110088138B (en) | 2016-09-23 | 2023-08-25 | 瑞泽恩制药公司 | anti-STEAP 2 antibodies, antibody drug conjugates and bispecific antigen binding molecules that bind STEAP2 and CD3 and uses thereof |
| GB201617466D0 (en) | 2016-10-14 | 2016-11-30 | Medimmune Ltd | Pyrrolobenzodiazepine conjugates |
| MX2019005330A (en) | 2016-11-08 | 2019-09-11 | Regeneron Pharma | Steroids and protein-conjugates thereof. |
| TWI782930B (en) | 2016-11-16 | 2022-11-11 | 美商再生元醫藥公司 | Anti-met antibodies, bispecific antigen binding molecules that bind met, and methods of use thereof |
| GB201702031D0 (en) | 2017-02-08 | 2017-03-22 | Medlmmune Ltd | Pyrrolobenzodiazepine-antibody conjugates |
| JP6671555B2 (en) | 2017-02-08 | 2020-03-25 | アーデーセー セラピューティクス ソシエテ アノニム | Pyrrolobenzodiazepine antibody conjugate |
| MX2019010769A (en) | 2017-03-24 | 2019-12-11 | Seattle Genetics Inc | Process for the preparation of glucuronide drug-linkers and intermediates thereof. |
| AU2018255876B2 (en) | 2017-04-18 | 2020-04-30 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
| US20200129637A1 (en) | 2017-04-20 | 2020-04-30 | Adc Therapeutics Sa | Combination therapy with an anti-axl antibody-drug conjugate |
| EP3624894A1 (en) | 2017-05-18 | 2020-03-25 | Regeneron Pharmaceuticals, Inc. | Cyclodextrin protein drug conjugates |
| WO2018213082A1 (en) | 2017-05-18 | 2018-11-22 | Regeneron Pharmaceuticals, Inc. | Bis-octahydrophenanthrene carboxamides and protein conjugates thereof |
| AU2018285562B2 (en) | 2017-06-14 | 2024-01-18 | Adc Therapeutics Sa | Dosage regimes for the administration of an anti-CD19 ADC |
| AU2018316532B2 (en) | 2017-08-18 | 2022-11-24 | Medimmune Limited | Pyrrolobenzodiazepine conjugates |
| CA3125713A1 (en) | 2017-09-29 | 2019-04-04 | Daiichi Sankyo Company, Limited | Antibody-pyrrolobenzodiazepine derivative conjugate |
| CN111601619A (en) | 2017-11-07 | 2020-08-28 | 里珍纳龙药品有限公司 | Hydrophilic linkers for antibody drug conjugates |
| CN111417409B (en) | 2017-11-14 | 2022-07-08 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepine conjugates |
| WO2019104289A1 (en) | 2017-11-27 | 2019-05-31 | Mersana Therapeutics, Inc. | Pyrrolobenzodiazepine antibody conjugates |
| TW201929908A (en) | 2017-12-21 | 2019-08-01 | 美商梅爾莎納醫療公司 | Pyrrolobenzodiazepine antibody conjugates |
| MX2020006994A (en) | 2018-01-08 | 2020-11-06 | Regeneron Pharma | Steroids and antibody-conjugates thereof. |
| GB201803342D0 (en) | 2018-03-01 | 2018-04-18 | Medimmune Ltd | Methods |
| GB201806022D0 (en) | 2018-04-12 | 2018-05-30 | Medimmune Ltd | Pyrrolobenzodiazepines and conjugates thereof |
| WO2019212965A1 (en) | 2018-04-30 | 2019-11-07 | Regeneron Pharmaceuticals, Inc. | Antibodies, and bispecific antigen-binding molecules that bind her2 and/or aplp2, conjugates, and uses thereof |
| CN112533951A (en) | 2018-05-09 | 2021-03-19 | 里珍纳龙药品有限公司 | anti-MSR 1 antibodies and methods of use thereof |
| MA52626A (en) | 2018-05-17 | 2021-03-24 | Regeneron Pharma | ANTI-CD63 ANTIBODIES, CONJUGATES AND THEIR USES |
| WO2019229536A2 (en) * | 2018-05-29 | 2019-12-05 | Intocell, Inc. | Novel benzodiazepine derivatives and uses thereof |
| WO2020106780A1 (en) | 2018-11-20 | 2020-05-28 | Regeneron Pharmaceuticals, Inc. | Bis-octahydrophenanthrene carboxamide derivatives and protein conjugates thereof for use as lxr agonists |
| CA3124106A1 (en) | 2018-12-21 | 2020-06-25 | Regeneron Pharmaceuticals, Inc. | Tubulysins and protein-tubulysin conjugates |
| US11666658B2 (en) | 2018-12-21 | 2023-06-06 | Regeneran Pharmaceuticals, Inc. | Rifamycin analogs and antibody-drug conjugates thereof |
| CN113905767A (en) | 2019-01-08 | 2022-01-07 | 里珍纳龙药品有限公司 | Traceless linkers and protein conjugates thereof |
| EP3927435A1 (en) | 2019-02-21 | 2021-12-29 | Regeneron Pharmaceuticals, Inc. | Methods of treating ocular cancer using anti-met antibodies and bispecific antigen binding molecules that bind met |
| CN110078749B (en) * | 2019-06-04 | 2021-01-01 | 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) | 3a, 3a' -difuran [2,3-b ] indoline compound, preparation method, pharmaceutical composition and application |
| CA3146933A1 (en) | 2019-09-16 | 2021-03-25 | Marcus KELLY | Radiolabeled met binding proteins for immuno-pet imaging |
| US11814428B2 (en) | 2019-09-19 | 2023-11-14 | Regeneron Pharmaceuticals, Inc. | Anti-PTCRA antibody-drug conjugates and uses thereof |
| WO2021080608A1 (en) | 2019-10-25 | 2021-04-29 | Medimmune, Llc | Branched moiety for use in conjugates |
| WO2021137646A1 (en) | 2019-12-31 | 2021-07-08 | 주식회사 레고켐바이오사이언스 | Pyrrolobenzodiazepine derivative and ligand-linker conjugate thereof |
| EP4093440A1 (en) | 2020-01-24 | 2022-11-30 | Regeneron Pharmaceuticals, Inc. | Protein-antiviral compound conjugates |
| US11958910B2 (en) | 2020-02-28 | 2024-04-16 | Regeneron Pharmaceuticals, Inc. | Bispecific antigen binding molecules that bind HER2, and methods of use thereof |
| CN115968304A (en) | 2020-04-16 | 2023-04-14 | 瑞泽恩制药公司 | Diels-Alder conjugation methods |
| US20230069722A1 (en) | 2020-06-24 | 2023-03-02 | Regeneron Pharmaceuticals, Inc. | Tubulysins and protein-tubulysin conjugates |
| MX2023000544A (en) | 2020-07-13 | 2023-02-13 | Regeneron Pharma | Camptothecin analogs conjugated to a glutamine residue in a protein, and their use. |
| WO2022056494A1 (en) | 2020-09-14 | 2022-03-17 | Regeneron Pharmaceuticals, Inc. | Antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof |
| IL301702A (en) | 2020-10-22 | 2023-05-01 | Regeneron Pharma | Anti-fgfr2 antibodies and methods of use thereof |
| WO2023009754A2 (en) | 2021-07-28 | 2023-02-02 | Regeneron Pharmaceuticals, Inc. | Protein-antiviral compound conjugates |
| US20230414775A1 (en) | 2021-12-29 | 2023-12-28 | Regeneron Pharmaceuticals, Inc. | Tubulysins and protein-tubulysin conjugates |
| US20230287138A1 (en) | 2022-01-12 | 2023-09-14 | Regneron Pharmaceuticals, Inc. | Protein-drug conjugates comprising camptothecin analogs and methods of use thereof |
| US20230277682A1 (en) | 2022-01-14 | 2023-09-07 | Regeneron Pharmaceuticals, Inc. | Verrucarin a derivatives and antibody drug conjugates thereof |
| WO2023173132A1 (en) | 2022-03-11 | 2023-09-14 | Regeneron Pharmaceuticals, Inc. | Anti-glp1r antibody-drug conjugates comprising glp1 peptidomimetics and uses thereof |
| WO2024020164A2 (en) | 2022-07-21 | 2024-01-25 | Firefly Bio, Inc. | Glucocorticoid receptor agonists and conjugates thereof |
Family Cites Families (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3361742A (en) | 1964-12-07 | 1968-01-02 | Hoffmann La Roche | 5-oxo-1h-pyrrolo-[2, 1-c][1, 4]-benzodiazepin-2-crylamides |
| US3523941A (en) | 1967-03-06 | 1970-08-11 | Hoffmann La Roche | Benzodiazepine compounds and process for their preparation |
| US3524849A (en) | 1967-10-27 | 1970-08-18 | Hoffmann La Roche | Process for the preparation of pyrrolo-benzodiazepine acrylamides and intermediates useful therein |
| JPS4843755B1 (en) | 1969-06-26 | 1973-12-20 | ||
| IL33558A (en) | 1968-12-30 | 1973-10-25 | Fujisawa Pharmaceutical Co | Antibiotic pyrrolo-benzodiazepine compound,its derivatives and processes for their production |
| FR2027356A1 (en) | 1968-12-30 | 1970-09-25 | Fujisawa Pharmaceutical Co | Benzodiazepinone antibiotics |
| JPS5382792U (en) | 1976-12-10 | 1978-07-08 | ||
| JPS585916B2 (en) | 1977-12-27 | 1983-02-02 | 株式会社ミドリ十字 | New benzodiazepine compounds |
| JPS5615289A (en) | 1979-07-17 | 1981-02-14 | Green Cross Corp:The | Novel benzodiazepinnbased compound 3 |
| JPH0353356Y2 (en) | 1981-02-06 | 1991-11-21 | ||
| CA1184175A (en) | 1981-02-27 | 1985-03-19 | Walter Hunkeler | Imidazodiazepines |
| CA1185602A (en) | 1981-02-27 | 1985-04-16 | Emilio Kyburz | Imidazodiazepines |
| CA1173441A (en) | 1981-02-27 | 1984-08-28 | Hoffmann-La Roche Limited | Imidazodiazepines |
| JPS58180487A (en) | 1982-04-16 | 1983-10-21 | Kyowa Hakko Kogyo Co Ltd | Antibiotic dc-81 and its preparation |
| JPS58180487U (en) | 1982-05-28 | 1983-12-02 | 松下電工株式会社 | Light beam alarm assembly |
| US4427588A (en) | 1982-11-08 | 1984-01-24 | Bristol-Myers Company | Process for conversion of oxotomaymycin to tomaymycin |
| US4427587A (en) | 1982-11-10 | 1984-01-24 | Bristol-Myers Company | Total synthesis of antitumor antibiotics BBM-2040A and BBM-2040B |
| JPS59152329A (en) | 1983-02-17 | 1984-08-31 | Green Cross Corp:The | Local disorder inhibitor |
| JPS59190992A (en) * | 1983-04-12 | 1984-10-29 | Green Cross Corp:The | Benzodiazepine derivative |
| FR2586683B1 (en) | 1985-08-29 | 1988-07-01 | Centre Nat Rech Scient | NOVEL NEOTHRAMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS |
| JP2660201B2 (en) | 1988-08-05 | 1997-10-08 | 塩野義製薬株式会社 | Novel pyrrolo [1,4] benzodiazepine derivatives and senile dementia drugs |
| FR2676230B1 (en) | 1991-05-07 | 1993-08-27 | Centre Nat Rech Scient | NOVEL PYRROLO [1,4] -BENZODIAZEPINES DERIVATIVES, PROCESS FOR THEIR PREPARATION AND MEDICAMENTS CONTAINING THEM. |
| GB9205051D0 (en) | 1992-03-09 | 1992-04-22 | Cancer Res Campaign Tech | Pyrrolobenzodiazepine derivatives,their preparation,and compositions containing them |
| FR2696176B1 (en) | 1992-09-28 | 1994-11-10 | Synthelabo | Piperidine derivatives, their preparation and their therapeutic application. |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| GB9316162D0 (en) | 1993-08-04 | 1993-09-22 | Zeneca Ltd | Fungicides |
| AU5094699A (en) | 1998-07-08 | 2000-02-01 | E-Ink Corporation | Methods for achieving improved color in microencapsulated electrophoretic devices |
| GB9818732D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collection of compounds |
| GB9818731D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Compounds |
| GB9818730D0 (en) | 1998-08-27 | 1998-10-21 | Univ Portsmouth | Collections of compounds |
| AU757510C (en) | 1998-08-27 | 2003-09-11 | Medimmune Limited | Pyrrolobenzodiazepines |
| US6909006B1 (en) | 1999-08-27 | 2005-06-21 | Spirogen Limited | Cyclopropylindole derivatives |
| US6660742B2 (en) | 2000-09-19 | 2003-12-09 | Taiho Pharmaceutical Co. Ltd. | Compositions and methods of the use thereof achiral analogues of CC-1065 and the duocarmycins |
| US6362331B1 (en) | 2001-03-30 | 2002-03-26 | Council Of Scientific And Industrial Research | Process for the preparation of antitumor agents |
| US6660856B2 (en) | 2002-03-08 | 2003-12-09 | Kaohsiung Medical University | Synthesis of pyrrolo[2,1-c][1,4]benzodiazepine analogues |
| ES2544527T3 (en) | 2002-07-31 | 2015-09-01 | Seattle Genetics, Inc. | Drug conjugates and their use to treat cancer, an autoimmune disease or an infectious disease |
| US20040138269A1 (en) | 2002-10-11 | 2004-07-15 | Sugen, Inc. | Substituted pyrroles as kinase inhibitors |
| GB0226593D0 (en) | 2002-11-14 | 2002-12-24 | Consultants Ltd | Compounds |
| ATE421967T1 (en) | 2003-03-31 | 2009-02-15 | Council Scient Ind Res | NON-CROSS-LINKING PYRROLOÄ2,1-CÜÄ1, 4ÜBENZODIAZEPINES AS POTENTIAL ANTITUMOR AGENTS AND THEIR PRODUCTION |
| GB0321295D0 (en) | 2003-09-11 | 2003-10-15 | Spirogen Ltd | Synthesis of protected pyrrolobenzodiazepines |
| GB0416511D0 (en) | 2003-10-22 | 2004-08-25 | Spirogen Ltd | Pyrrolobenzodiazepines |
| AU2004284075A1 (en) | 2003-10-22 | 2005-05-06 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Pyrrolobenzodiazepine derivatives, compositions comprising the same and methods related thereto |
| ZA200603619B (en) | 2003-11-06 | 2008-10-29 | Seattle Genetics Inc | Monomethylvaline compounds capable of conjugation to ligands |
| JP5064037B2 (en) | 2004-02-23 | 2012-10-31 | ジェネンテック， インコーポレイテッド | Heterocyclic self-destructive linkers and conjugates |
| GB0404578D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines |
| PT2270010E (en) * | 2004-03-01 | 2012-03-12 | Spirogen Ltd | 11-hydroxy-5h-pyrrolo[2,1-c][1,4]benzodiazepin-5-one derivatives as key intermediates for the preparation of c2 substituted pyrrolobenzodiazepins |
| GB0404577D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Pyrrolobenzodiazepines |
| GB0404574D0 (en) | 2004-03-01 | 2004-04-07 | Spirogen Ltd | Amino acids |
| DE102004010943A1 (en) | 2004-03-03 | 2005-09-29 | Degussa Ag | Process for the preparation of N-protected 4-ketproline derivatives |
| US7528126B2 (en) | 2004-03-09 | 2009-05-05 | Spirogen Limited | Pyrrolobenzodiazepines |
| FR2869231B1 (en) | 2004-04-27 | 2008-03-14 | Sod Conseils Rech Applic | THERAPEUTIC COMPOSITION CONTAINING AT LEAST ONE PYRROLOBENZODIAZEPINE DERIVATIVE AND FLUDARABINE |
| GB0410725D0 (en) | 2004-05-13 | 2004-06-16 | Spirogen Ltd | Pyrrolobenzodiazepine therapeutic agents |
| NZ580115A (en) | 2004-09-23 | 2010-10-29 | Genentech Inc | Cysteine engineered antibody light chains and conjugates |
| RU2364643C2 (en) | 2004-12-24 | 2009-08-20 | Сова Денко К.К. | Method of obtaining thermoelectric semiconductor alloy, module of thermoelectric treansformation and thermoelectric device for electric energy generation |
| CN101203241B (en) | 2005-04-19 | 2012-02-22 | 西雅图基因公司 | Humanized anti-CD70 binding agents and uses thereof |
| MX2007013039A (en) | 2005-04-21 | 2008-03-13 | Spirogen Ltd | Pyrrolobenzodiazepines. |
| GB0508084D0 (en) * | 2005-04-21 | 2005-06-01 | Spirogen Ltd | Pyrrolobenzodiazepines |
| US20070154906A1 (en) | 2005-10-05 | 2007-07-05 | Spirogen Ltd. | Methods to identify therapeutic candidates |
| US8637664B2 (en) | 2005-10-05 | 2014-01-28 | Spirogen Sarl | Alkyl 4- [4- (5-oxo-2,3,5, 11a-tetrahydo-5H-pyrrolo [2, 1-c] [1,4] benzodiazepine-8-yloxy)-butyrylamino]-1H-pyrrole-2-carboxylate derivatives and related compounds for the treatment of a proliferative disease |
| SI1813614T1 (en) | 2006-01-25 | 2012-01-31 | Sanofi 174 | Cytotoxic agents comprising new tomaymycin derivatives |
| JP5622390B2 (en) | 2006-07-18 | 2014-11-12 | サノフイ | Anti-EPHA2 antagonist antibody for cancer treatment |
| EP1914242A1 (en) | 2006-10-19 | 2008-04-23 | Sanofi-Aventis | Novel anti-CD38 antibodies for the treatment of cancer |
| WO2008050140A2 (en) | 2006-10-27 | 2008-05-02 | Spirogen Limited | Compounds for treatment of parasitic infection |
| ES2523915T5 (en) | 2006-12-01 | 2022-05-26 | Seagen Inc | Variant Target Binding Agents and Uses Thereof |
| US8465883B2 (en) | 2007-07-11 | 2013-06-18 | The Regents Of The University Of California | Nanostructured polymer membranes for proton conduction |
| ES2435779T3 (en) | 2007-07-19 | 2013-12-23 | Sanofi | Cytotoxic agents comprising new tomaimycin derivatives and their therapeutic use |
| GB0722087D0 (en) | 2007-11-09 | 2007-12-19 | Spirogen Ltd | Polyamides |
| GB0722088D0 (en) | 2007-11-09 | 2007-12-19 | Spirogen Ltd | Pyrrolobenzodiazepines |
| US20090310707A1 (en) | 2008-06-17 | 2009-12-17 | Jung-Fu Cheng | Transmitter and method for transmitting soft pilot symbols in a digital communication system |
| GB0813432D0 (en) | 2008-07-22 | 2008-08-27 | Spirogen Ltd | Pyrrolobenzodiazepines |
| GB0819097D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| GB0819095D0 (en) | 2008-10-17 | 2008-11-26 | Spirogen Ltd | Pyrrolobenzodiazepines |
| EP3100745B1 (en) | 2009-02-05 | 2018-04-18 | Immunogen, Inc. | Novel benzodiazepine derivatives |
| FR2949469A1 (en) | 2009-08-25 | 2011-03-04 | Sanofi Aventis | ANTICANCER DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION |
| WO2011038159A2 (en) | 2009-09-24 | 2011-03-31 | Seattle Genetics, Inc. | Dr5 ligand drug conjugates |
| US9040526B2 (en) | 2010-02-09 | 2015-05-26 | Bristol-Myers Squibb Company | Benzylpyrrolidinone derivatives as modulators of chemokine receptor activity |
| JP5972864B2 (en) | 2010-04-15 | 2016-08-17 | メディミューン リミテッド | Pyrrolobenzodiazepines and their conjugates |
| JP5870400B2 (en) | 2010-04-15 | 2016-03-01 | シアトル ジェネティクス，インコーポレーテッド | Targeted pyrrolobenzodiazepine conjugates |
| GB201006340D0 (en) | 2010-04-15 | 2010-06-02 | Spirogen Ltd | Synthesis method and intermediates |
| BR112012026410B8 (en) | 2010-04-15 | 2023-01-31 | Spirogen Dev Sarl | COMPOUND AND CONJUGATE OF PYROLOBENZODIAZEPINE AND USES THEREOF |
| KR20140010067A (en) | 2011-02-15 | 2014-01-23 | 이뮤노젠 아이엔씨 | Methods of preparation of conjugates |
| KR101860174B1 (en) | 2011-09-20 | 2018-05-21 | 메디뮨 리미티드 | Pyrrolobenzodiazepines as unsymmetrical dimeric pbd compounds for inclusion in targeted conjugates |
| WO2013053872A1 (en) | 2011-10-14 | 2013-04-18 | Spirogen Sàrl | Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
| CN103987384A (en) | 2011-10-14 | 2014-08-13 | 西雅图基因公司 | Pyrrolobenzodiazepines and targeted conjugates |
| RS54446B1 (en) | 2011-10-14 | 2016-06-30 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| WO2013053873A1 (en) | 2011-10-14 | 2013-04-18 | Spirogen Sàrl | Pyrrolobenzodiazepines |
| WO2013055993A1 (en) | 2011-10-14 | 2013-04-18 | Seattle Genetics, Inc. | Pyrrolobenzodiazepines and targeted conjugates |
| EP2751110B1 (en) | 2011-10-14 | 2017-04-19 | MedImmune Limited | Asymmetrical bis-(5H-Pyrrolo[2,1-c][1,4]benzodiazepin-5-one) derivatives for the treatment of proliferative and autoimmune diseases |
| MX2014013144A (en) | 2012-04-30 | 2015-05-11 | Ucl Business Plc | Pyrrolobenzodiazepines. |
| WO2013164593A1 (en) | 2012-04-30 | 2013-11-07 | Spirogen Sàrl | Pyrrolobenzodiazepines |
| AU2013288929A1 (en) | 2012-07-09 | 2014-12-04 | Genentech, Inc. | Immunoconjugates comprising anti-CD22 antibodies |
| IN2014DN10652A (en) | 2012-07-09 | 2015-09-11 | Genentech Inc | |
| RU2015106673A (en) | 2012-08-02 | 2016-09-20 | Дженентек, Инк. | ANTIBODIES TO TYPE B ENDOTHELIN RECEPTOR (ETBR) AND IMMUNOCONJUGATES |
| EP2906249B1 (en) | 2012-10-12 | 2018-06-27 | MedImmune Limited | Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation |
| US9931414B2 (en) | 2012-10-12 | 2018-04-03 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| US10695433B2 (en) | 2012-10-12 | 2020-06-30 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| WO2014057118A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sarl | Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| WO2014057114A1 (en) | 2012-10-12 | 2014-04-17 | Adc Therapeutics Sàrl | Pyrrolobenzodiazepine-anti-psma antibody conjugates |
| BR112015008177A2 (en) | 2012-10-12 | 2017-09-19 | Adc Therapeutics Sarl | pyrrolobenzodiazepine conjugates - antibody |
| EP2906296B1 (en) | 2012-10-12 | 2018-03-21 | ADC Therapeutics SA | Pyrrolobenzodiazepine-antibody conjugates |
| PL2906253T3 (en) | 2012-10-12 | 2019-02-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine - anti-psma antibody conjugates |
| CN110256469B (en) | 2012-10-12 | 2022-05-17 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines and conjugates thereof |
| LT2839860T (en) | 2012-10-12 | 2019-07-10 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof |
| RS56520B1 (en) | 2012-10-12 | 2018-02-28 | Adc Therapeutics Sa | Pyrrolobenzodiazepine-anti-cd22 antibody conjugates |
| JP6527466B2 (en) | 2012-12-21 | 2019-06-05 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | Asymmetric pyrrolobenzodiazepine dimers for use in the treatment of proliferative and autoimmune diseases |
| CN110452242A (en) | 2012-12-21 | 2019-11-15 | 麦迪穆有限责任公司 | Pyrrolobenzodiazepines Zhuo and its conjugate |
| DK2958944T3 (en) | 2013-02-22 | 2019-06-24 | Abbvie Stemcentrx Llc | ANTI-DLL3 ANTISTOF PBD CONJUGATES AND USES THEREOF |
| CA2905181C (en) | 2013-03-13 | 2020-06-02 | Medimmune Limited | Pyrrolobenzodiazepines and conjugates thereof for providing targeted therapy |
| EA027910B1 (en) | 2013-03-13 | 2017-09-29 | Медимьюн Лимитед | Pyrrolobenzodiazepines and conjugates thereof |
| JP6340019B2 (en) | 2013-03-13 | 2018-06-06 | メドイミューン・リミテッドＭｅｄＩｍｍｕｎｅ Ｌｉｍｉｔｅｄ | Pyrrolobenzodiazepine and its conjugates |
| JP2016518382A (en) | 2013-04-26 | 2016-06-23 | ピエール、ファーブル、メディカマン | Axl antibody drug conjugate and use thereof for the treatment of cancer |
| GB201317982D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| US9956299B2 (en) | 2013-10-11 | 2018-05-01 | Medimmune Limited | Pyrrolobenzodiazepine—antibody conjugates |
| US20160256561A1 (en) | 2013-10-11 | 2016-09-08 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| GB201317981D0 (en) | 2013-10-11 | 2013-11-27 | Spirogen Sarl | Pyrrolobenzodiazepines and conjugates thereof |
| EP3054983B1 (en) | 2013-10-11 | 2019-03-20 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| EP3054985B1 (en) | 2013-10-11 | 2018-12-26 | Medimmune Limited | Pyrrolobenzodiazepine-antibody conjugates |
| EA033456B1 (en) | 2013-12-16 | 2019-10-31 | Genentech Inc | Antibody-drug conjugates comprising peptidomimetic linkers |
| GB201406767D0 (en) | 2014-04-15 | 2014-05-28 | Cancer Rec Tech Ltd | Humanized anti-Tn-MUC1 antibodies anf their conjugates |
-
2012
- 2012-10-12 WO PCT/EP2012/070233 patent/WO2013053873A1/en active Application Filing
- 2012-10-12 KR KR1020147012411A patent/KR101891859B1/en active IP Right Grant
- 2012-10-12 US US14/351,173 patent/US9399073B2/en active Active
- 2012-10-12 AU AU2012322934A patent/AU2012322934B2/en not_active Ceased
- 2012-10-12 CA CA2850103A patent/CA2850103C/en not_active Expired - Fee Related
- 2012-10-12 SG SG11201401021TA patent/SG11201401021TA/en unknown
- 2012-10-12 CN CN201280062290.1A patent/CN103998450B/en not_active Expired - Fee Related
- 2012-10-12 EP EP12772782.4A patent/EP2751111B1/en not_active Not-in-force
- 2012-10-12 JP JP2014535097A patent/JP6170497B2/en not_active Expired - Fee Related
- 2012-10-12 EA EA201490535A patent/EA028457B1/en unknown
- 2012-10-12 BR BR112014008888A patent/BR112014008888A2/en not_active Application Discontinuation
- 2012-10-12 MX MX2014004557A patent/MX341523B/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| US20140274907A1 (en) | 2014-09-18 |
| CA2850103C (en) | 2019-09-10 |
| EP2751111A1 (en) | 2014-07-09 |
| MX2014004557A (en) | 2015-02-12 |
| EA201490535A1 (en) | 2014-09-30 |
| CN103998450B (en) | 2017-03-08 |
| KR101891859B1 (en) | 2018-08-24 |
| KR20140099449A (en) | 2014-08-12 |
| EP2751111B1 (en) | 2017-04-26 |
| JP2014528467A (en) | 2014-10-27 |
| MX341523B (en) | 2016-08-24 |
| BR112014008888A2 (en) | 2017-04-18 |
| WO2013053873A1 (en) | 2013-04-18 |
| AU2012322934B2 (en) | 2016-09-08 |
| US9399073B2 (en) | 2016-07-26 |
| EA028457B1 (en) | 2017-11-30 |
| CA2850103A1 (en) | 2013-04-18 |
| JP6170497B2 (en) | 2017-07-26 |
| AU2012322934A1 (en) | 2014-05-29 |
| CN103998450A (en) | 2014-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201401021TA (en) | Pyrrolobenzodiazepines | |
| HK1208444A1 (en) | Pyrrolobenzodiazepines | |
| HK1208217A1 (en) | Pyrrolobenzodiazepines | |
| DK3798230T3 (en) | Terapeutiske antistoffer | |
| EP2790561A4 (en) | Dishmachine | |
| EP2755962A4 (en) | Azaindazoles | |
| EP2715659A4 (en) | Überfeed | |
| EP2754063A4 (en) | Smb2 scaleout | |
| EP2776444A4 (en) | Dihydropteridinones | |
| EP2723631A4 (en) | Quadfolier | |
| AP2014007621A0 (en) | 2-Thiopyrimidinones | |
| EP2695208A4 (en) | Micro-thermocouple | |
| EP2679138A4 (en) | Endsoscope | |
| EP2708561A4 (en) | Bio-pin | |
| DK2770906T3 (en) | Applanationstonometer | |
| EP2684382A4 (en) | Earpuff | |
| EP2698098A4 (en) | Campimeter | |
| EP2694655A4 (en) | pAVEC | |
| GB2512771B (en) | Ablutionary fitting | |
| EP2702929A4 (en) | Campimeter | |
| GB201101727D0 (en) | Obuoy | |
| GB201100001D0 (en) | TidySqueeze2 | |
| AU4540P (en) | BUNNAN Baloskion tetraphyllum | |
| AU5171P (en) | Sunparamiho Mandevilla xamabilis | |
| AU5031P (en) | BESYS Beschorneria yuccoides |